{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:27:39Z","timestamp":1788838059634,"version":"build-2803163510"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016714","name":"University of Sharjah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016714","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100024160","name":"ASPIRE","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100024160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Macrolide antibiotic azithromycin is widely used in clinical practice to treat respiratory tract infections and inflammatory diseases. However, its mechanism of action is not fully understood. Given the involvement of the CD27 pathway in the pathophysiology of various T-lymphocyte-mediated inflammatory, autoimmune, and lymphoproliferative diseases, we examined the impact of AZM on CD27 regulation and potential consequences on CD4+ and CD8+ T-cell phenotypes. Using cellular immunology approaches on healthy donors\u2019 peripheral blood mononuclear cells, we demonstrate AZM-mediated downregulation of surface CD27 expression as well as its extracellular release as soluble CD27. Notably, AZM-exposed CD27high (hi) cells were defective in their ability to expand compared to CD27intermediate (Int) and CD27low (lo) subsets. The defective CD27hi subset expansion was found to be associated with impaired cell proliferation and cell division. At the molecular level, the CD27hi subset exhibited lower mTOR activity than other subsets. Functionally, AZM treatment resulted in marked depletion of helper CD4+ (Th1) and cytotoxic CD8+ T-lymphocyte (Tc1)-associated CXCR3+CD27hi effector cells and inhibition of inflammatory cytokine IFN-\u03b3 production. These findings provide mechanistic insights on immunomodulatory features of AZM on T-lymphocyte by altering the CD27 pathway. From a clinical perspective, this study also sheds light on potential clinical benefits observed in patients on prophylactic AZM regimens against various respiratory diseases and opens avenues for future adjunct therapy against Th1- and Tc1-dominated inflammatory and autoimmune diseases.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1447625","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T04:22:41Z","timestamp":1723695761000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Azithromycin targets the CD27 pathway to modulate CD27hi T-lymphocyte expansion and type-1 effector phenotype"],"prefix":"10.3389","volume":"15","author":[{"given":"Abdul Wahid","family":"Ansari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju Nidagodu","family":"Jayakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fareed","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thenmozhi","family":"Venkatachalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Salameh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hema","family":"Unnikannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thesni","family":"Raheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Khader","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassam","family":"Mahboub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basel K.","family":"Al-Ramadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qutayba","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Steinhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rifat","family":"Hamoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31281-3","article-title":"Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): A randomised, double-blind, placebo-controlled trial","volume":"390","author":"Gibson","year":"2017","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1800628","DOI":"10.1183\/13993003.00628-2018","article-title":"The potential impact of azithromycin in idiopathic pulmonary fibrosis","volume":"53","author":"Macaluso","year":"2019","journal-title":"Eur Respir J"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.1937","article-title":"Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial","volume":"309","author":"Altenburg","year":"2013","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.2011.01343.x","article-title":"Azithromycin suppresses proliferation, interleukin production and mitogen-activated protein kinases in human peripheral-blood mononuclear cells stimulated with bacterial superantigen","volume":"63","author":"Hiwatashi","year":"2011","journal-title":"J Pharm Pharmacol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01576.x","article-title":"Azithromycin distinctively modulates classical activation of human monocytes in vitro","volume":"165","author":"Vran\u010di\u0107","year":"2012","journal-title":"Br J Pharmacol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2010.12.010","article-title":"Azithromycin inhibits macrophage interleukin-1\u03b2 production through inhibition of activator protein-1 in lipopolysaccharide-induced murine pulmonary neutrophilia","volume":"11","author":"Bosnar","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1600-6143.2006.01586.x","article-title":"Macrolides inhibit IL17-induced IL8 and 8-isoprostane release from human airway smooth muscle cells","volume":"7","author":"Vanaudenaerde","year":"2007","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200601-071OC","article-title":"Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome","volume":"174","author":"Verleden","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.3.277","article-title":"In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection","volume":"33","author":"Gladue","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/25.suppl_A.73","article-title":"The pharmacokinetics of azithromycin in human serum and tissues","author":"Foulds","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01142-06","article-title":"Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells","volume":"51","author":"Cigana","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e00058","DOI":"10.1002\/prp2.58","article-title":"Azithromycin inhibits nuclear factor-\u03baB activation during lung inflammation: an in vivo imaging study","volume":"2","author":"Stellari","year":"2014","journal-title":"Pharmacol Res Perspect"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12942","article-title":"Azithromycin and the treatment of lymphocytic airway inflammation after lung transplantation","volume":"14","author":"Vos","year":"2014","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12931-017-0608-8","article-title":"Azithromycin decreases NALP3 mRNA stability in monocytes to limit inflammasome-dependent inflammation","volume":"18","author":"Lendermon","year":"2017","journal-title":"Respir Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1801228","article-title":"Azithromycin polarizes macrophages to an M2 phenotype via inhibition of the STAT1 and NF-\u03baB signaling pathways","volume":"203","author":"Haydar","year":"2019","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.11.090","article-title":"Azithromycin treats diffuse panbronchiolitis by targeting T cells via inhibition of mTOR pathway","volume":"110","author":"Weng","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/srep07438","article-title":"Azithromycin suppresses CD4+ T-cell activation by direct modulation of mTOR activity","volume":"4","author":"Ratzinger","year":"2014","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110831","article-title":"Azithromycin downregulates ICOS (CD278) and OX40 (CD134) expression and mTOR activity of TCR-activated T cells to inhibit proliferation","volume":"124","author":"Ansari","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.556579","article-title":"Azithromycin differentially alters TCR-activated helper T cell subset phenotype and effector function","volume":"11","author":"Ansari","year":"2020","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.139.5.1589","article-title":"Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen","volume":"139","author":"van Lier","year":"1987","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nri2526","article-title":"The role of TNF superfamily members in T-cell function and diseases","volume":"9","author":"Croft","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.146.8.2488","article-title":"Regulation of expression of CD27, a T cell-specific member of a novel family of membrane receptors","volume":"146","author":"de Jong","year":"1991","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.9.1407","article-title":"Phenotypic and functional separation of memory and effector human CD8+ T cells","volume":"186","author":"Hamann","year":"1997","journal-title":"J Exp Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/80877","article-title":"CD27 is required for generation and long-term maintenance of T cell immunity","volume":"1","author":"Hendriks","year":"2000","journal-title":"Nat Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.152.4.1762","article-title":"Characterization of the human CD27 ligand, a novel member of the TNF gene family","volume":"152","author":"Hintzen","year":"1994","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI40178","article-title":"CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production","volume":"120","author":"Peperzak","year":"2010","journal-title":"J Clin Invest"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(01)00236-9","article-title":"Constitutive CD27\/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion","volume":"15","author":"Arens","year":"2001","journal-title":"Immunity"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20030916","article-title":"CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool","volume":"198","author":"Hendriks","year":"2003","journal-title":"J Exp Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.21.13353","article-title":"CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase\/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase","volume":"273","author":"Akiba","year":"1998","journal-title":"J Biol Chem"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/(ISSN)1521-4141","article-title":"The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2","volume":"28","author":"Gravestein","year":"1998","journal-title":"Eur J Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1000159","article-title":"The Pim kinase pathway contributes to survival signaling in primed CD8+ T cells upon CD27 costimulation","volume":"185","author":"Peperzak","year":"2010","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxm033","article-title":"CD27-CD70 interactions sensitise naive CD4+ T cells for IL-12-induced Th1 cell development","volume":"19","author":"van Oosterwijk","year":"2007","journal-title":"Int Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201343579","article-title":"CD27 costimulation contributes substantially to the expansion of functional memory CD8(+) T cells after peptide immunization","volume":"43","author":"Taraban","year":"2013","journal-title":"Eur J Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80702-3","article-title":"A novel transcription factor, T-bet, directs Th1 lineage commitment","volume":"100","author":"Szabo","year":"2000","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/ni.1731","article-title":"The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation","volume":"10","author":"Koch","year":"2009","journal-title":"Nat Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4049\/jimmunol.147.1.29","article-title":"A soluble form of the human T cell differentiation antigen CD27 is released after triggering of the TCR\/CD3 complex","volume":"147","author":"Hintzen","year":"1991","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1996.0106","article-title":"Expression of the activation antigen CD27 in rheumatoid arthritis","volume":"80","author":"Tak","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1996.0184","article-title":"Elevated soluble CD27 levels in serum of patients with systemic lupus erythematosus","volume":"81","author":"Font","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2006.03214.x","article-title":"Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice","volume":"146","author":"Ito","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/nri3661","article-title":"Cytokines in inflammatory bowel disease","volume":"14","author":"Neurath","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.159.6.2652","article-title":"CD154\/CD40 and CD70\/CD27 interactions have different and sequential functions in T cell-dependent B cell responses: enhancement of plasma cell differentiation by CD27 signaling","volume":"159","author":"Jacquot","year":"1997","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.24.11249","article-title":"CD27-CD70 interactions regulate B-cell activation by T cells","volume":"92","author":"Kobata","year":"1995","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2004.05.011","article-title":"Clarithromycin and azithromycin induce apoptosis of activated lymphocytes via down-regulation of Bcl-xL","volume":"4","author":"Mizunoe","year":"2004","journal-title":"Int Immunopharmacol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2004.03.022","article-title":"Macrolide antibiotics induce apoptosis of human peripheral lymphocytes","volume":"24","author":"Ishimatsu","year":"2004","journal-title":"Vitro Int J Antimicrob Agents"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900288","article-title":"CD27 promotes CD4+ Effector T cell survival in response to tissue self-antigen","volume":"203","author":"Remedios","year":"2019","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M513613200","article-title":"T-bet binding to newly identified target gene promoters is cell type-independent but results in variable context-dependent functional effects","volume":"281","author":"Beima","year":"2006","journal-title":"J Biol Chem"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2016.09.012","article-title":"Azithromycin modulates immune response of human monocyte-derived dendritic cells and CD4(+) T cells","volume":"40","author":"Lin","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.162.5.2775","article-title":"Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation","volume":"162","author":"Powell","year":"1999","journal-title":"J Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0609706104","article-title":"CD27 mediates interleukin-2-independent clonal expansion of the CD8+ T cell without effector differentiation","volume":"103","author":"Carr","year":"2006","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.09.002","article-title":"The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism","volume":"33","author":"Powell","year":"2010","journal-title":"Immunity"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.10.1515","article-title":"Requirement of the chemokine receptor CXCR3 for acute allograft rejection","volume":"192","author":"Hancock","year":"2000","journal-title":"J Exp Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016926","article-title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","volume":"140","author":"Vallet","year":"2022","journal-title":"Blood"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1447625\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T04:22:45Z","timestamp":1723695765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1447625\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":53,"alternative-id":["10.3389\/fimmu.2024.1447625"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1447625","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,15]]},"article-number":"1447625"}}